ʻO ka maʻi hypoglycemic Novonorm: nā ʻōlelo no ka hoʻohana ʻana, nā kumukūʻai, nā loiloi, nā analogues

Pin
Send
Share
Send

Ma kahi maʻi like ʻole e like me ka maʻi maʻi maʻi maʻi e loaʻa ʻia i kēlā me kēia lā a me ka nui o nā mea maʻi o nā ʻōpiopio like ʻole.

ʻO ka hiʻohiʻona nui o ka mālama ʻia he meaʻai kūikawā, kahi pono e hui pū ʻia e kekahi hana kino.

A pinepine, ma kahi o kēia, ua kuhikuhi ka poʻe akamai i ka lāʻau lapaʻau e hoʻonui i ka kiʻekiʻe o ka insulin i ke koko. ʻO kekahi o kēia mau lāʻau ʻoi aku ʻo Novonorm, nā ʻōlelo e aʻo ai i nā mea e kūkākūkā ma hope aku.

Ka hana lāʻau lapaʻau

ʻO ka lāʻau lapaʻau ʻo Novonorm kahi lāʻau lapaʻau e pili ana i ka hui o nā mea lawelawe waha-waha hypoglycemic poto. Hiki iā ia ke pale aku i nā kaila potassium-adenosine triphosphate i loko o nā membran o nā cell beta.

Ma hope o kēia, ua hoʻokaʻawale ka membrane a me nā hāmeʻa o ka calcium, a ʻo lākou, e kōkua i ka hoʻonui ʻana i ka nui o nā kalaiola i loko o ke kōpaʻa beta. ʻO ka mea hana ikaika ka repaglinide.

ʻO ka hiʻohiʻona nui o ka lāʻau lapaʻau ka hiki ke hoʻemi i ka glucose koko, ʻo ia no ka pōkole o ka hapa ola. ʻAʻole makaʻu nā mea maʻi e lawe nei iā Novonorm e mālama i ka meaʻaiʻai manu ʻole, ʻaʻole ʻia i ʻae ʻia i ka wā e lawe ai i nā ʻaila hypoglycemic ʻē aʻe.

Ma hope o ka lawelawe waha mua o ka lāʻau lapaʻau, ka hopena o ka lāʻau lapaʻau, e kōkua ana e hoʻonui i ka manaʻo o ka insulin hormone i loko o ke koko koko, ua hoʻokō ma hope o 10-30 mau minuke. ʻO ka emi ʻana o ke komo ʻana o ka plasma o ka mea ikaika e hana ana ma hope o ʻehā mau hola mai ka manawa o ka lawe ʻana i kēia lāʻau lapaʻau. Ma hope o ka hoʻoponopono waha ʻana o Novonorm, ua hōʻea ka ʻike maka kiʻekiʻe o ka waihona ma hope o hoʻokahi hola.

Nā hōʻailona no ka hoʻohana ʻana

ʻO ka hoʻomākaukau kaukau ʻana ʻo Novonorm i manaʻo ʻia no ka hoʻohana ʻana me:

  • i ka manawa o kahi maʻi paʻakikī i hui pū me ka metformin, a i ʻole hoʻohana i ka thiazolidinediones. I kēia hihia, ua hoʻohana ʻia ka lāʻau hoʻokō inā ʻaʻole i hāʻawi mai ʻo monotherapy i kekahi hopena i nā maʻi;
  • diabetes type 2. Hoʻomaopopo ʻia ka lāʻau lapaʻau inā ʻaʻole hāʻawi ʻoi aku ka hopena i ka hopena, me ka hoʻouka a me ke kaumaha.
Hoʻohana hou ʻia ka lāʻau lapaʻau Novonorm ma ke ʻano he meaʻai i ka meaʻai, a me ka hana kino.

Nā ʻōkuhi no ka hoʻohana

Noi wale ʻia ʻo Novonorm e like me ke ana no ka ʻai ʻana me ka hana maʻamau. Pono kēia e hōʻemi i ka pae o ka glucose i ke koko o ke kanaka.

Nā papa āpau Novonorm

ʻO nā ʻōlelo i hoʻohana ʻia no ka hoʻohana ʻana i nā papa Novonorm e hōʻike pono e lawe ʻia ka lāʻau ma ke alo o mua o ka papa ʻaina nui, a ʻano ka nui o nā helu he ʻelua a ʻehā mau manawa i ka lā. I ka manawa like, hana maikaʻi ʻia kēia 15 mau minuke ma mua o ka pāʻina. He mea kūpono ia e hoʻomanaʻo inā ʻaʻole nele i ka mea maʻi no ka mea nui ka ʻaina, a laila ʻaʻole pono nā lāʻau lapaʻau.

ʻAʻole ʻāpono ʻia ka papa papaʻa e ʻōleo, a me ka ʻōwili ʻana, pono holo a lawe ʻia hoʻi i ka waha, holoi ʻia me ka nui o ka wai. ʻO ka lōʻihi o ke kauʻana i nā lāʻau, a me nā kaha pono o ka lāʻau lapaʻau e hoʻoholo ʻia no kēlā me kēia maʻi e ka neʻe i ke kauka.

Hoʻomoe ka hoʻomaka ʻana no ka maʻi pākahi o 0.5 milligrams o ka repaglinide.

Ma hope o hoʻokahi a ʻelua paha mau pule mai ka hoʻomaka ʻana o ka lāʻau me kēia lāʻau lapaʻau, hoʻonui ʻia ka dosis. I ka manawa o kona hoʻohana ʻana, pono ia e kiaʻi pinepine i ka glucose koko i mea e hoʻoholo ai e like me ka hoʻokūkū pono ʻia ka hopena o ka liʻiliʻi loa o ka lāʻau lapaʻau ma ke kino.

ʻO ka nui o ka wai i koho ʻia e nā Novonorm he ʻehā milligrams, a ʻaʻole pono nā lāʻau o kēlā me kēia lā e 16 mau miligram. ʻO nā ʻōpio ka mea i hoʻohana i nā ʻaina hypoglycemic oral ma mua o Novonorm e kuhikuhi pinepine i hoʻokahi milligram o ka repaglinide i kahi ma mua.

ʻO nā maʻi e nāwaliwali ana a kala ʻole, pono e koho pono i ka dosis. Hoʻomaʻamaʻa ʻia ia no kēlā poʻe me ka liʻiliʻi loa. A me nā ʻoihana paʻakikī me nā lāʻau Metformin a me Novonorm, pono paha e koi ʻia he nui haʻahaʻa ma mua o ka monotherapy me kēia lāʻau lapaʻau.

ʻAʻole pono nā mea maʻi e loaʻa hou i nā hana renal i ka hoʻoponopono mua ʻana o ka lāʻau, akā pono e hoʻomanaʻo e pono e mālama ʻia ka mālama ʻana i ka wā e hoʻonui ai i ka dosage o Novonorm.

Nā hopena hopena

Haumaha ʻia ka lāʻau Novonorm akā naʻe, i kekahi mau hihia, aia kahi hoʻomohala i nā hōʻailona ʻaoʻao i hōʻike i nā ʻōnaehana like ʻole, e like me:

  • ninini
  • utuka
  • kuʻi ʻana i ka ululā;
  • eha epigastric;
  • urticaria;
  • huu
  • ʻili kino ʻili;
  • hoʻonui nui o nā hana enina;
  • ke kumu o ka hōʻeha o nā maʻi hōʻeha (ʻoi aku ka hōʻailona like ʻole, eia nō naʻe, ʻaʻole ia he hōʻike ʻia no ka pili ʻole o kēia kuhi me ka hoʻohana ʻana o Novonorm);
  • i ka maʻi hypoglycemia (e kū'ē i kēia mau ʻōuli, ʻo ke hoʻohana ʻana i nā mea kālaiʻai e lilo i hopena kūpono).
  • ka hana ʻana o ka hypoglycemia koʻikoʻi (me kēia ʻōuli, pono e lawelawe ʻia ka glucose i ka makua);
  • ka waihua o ka ʻike pōkole iki (e hele mai kēia hōʻailona ma muli o ke kahe ʻana o nā pae glucose glucose).

Nā Hoʻohui

Hoʻokomo ʻia ka lāʻau lapaʻau no ka hoʻohana ʻana i nā maʻi i loaʻa i:

  • uhaiki ikaika;
  • precoma hoʻokaʻawale;
  • diabetes ketoacidosis;
  • i ka wā hāpai;
  • maʻi mellitus type 1;
  • i ka wā lactation;
  • maʻi koma maʻi;
  • makahiki umauma i ka 18 makahiki;
  • hypersensitivity i ka lāʻau lapaʻau, a i kāna ʻāpana pilikino;
  • i ke kūlana o ka mea maʻi, ka mea e koi ai i ka therapy insulin (ʻo ke ʻano he maʻi ka maʻi ʻeha, ka hōʻino ʻana o nā hōʻino, a me nā mea hou aku).

Hiki ke hoʻohana ʻia ka lāʻau lapaʻau i loko o kēia mau hihia, eia naʻe, pono e mālama ʻia ka mālama ʻana i kēia mau maʻi.

  • febrile syndrome;
  • makahiki ʻoi aku ka 75 makahiki keu aku;
  • pilikia ʻole;
  • waiʻona.

Hoʻohui nūhou

Ke hoʻohana nei i ka lāʻau lapaʻau, pono ia e noʻonoʻo i kekahi mau lāʻau i hoʻohana pū ʻia me ka hoʻonaʻauao pū me ia i nā peka o ka lolo, hiki iā ia ke hoʻoponopono ʻia.

I ka pili ʻana o Novonorm me nā lāʻau lapaʻau ʻē aʻe, e like me: glarinthromycin, anabolic steroid, non-selective beta-blockers, ethanol, monoamine oxidase inhibitors, kahi hopena e hoʻonui ai i ka hapalua-ola o ka repaglinide.

ʻO nā loli nui i ka pharmacokinetics o ka mea ikaika o Novonorm ʻaʻole i hele pū me ka hoʻohana pū ʻana o ka lāʻau lapaʻau me: Nifedipine, Cimetidine, Simvastatin, estrogens.

Ke keu

ʻOiai ke lawe nei i kēia lāʻau lapaʻau, aia ka manawa i kahi overdose inā ʻaʻole ʻoe e hahai i nā ʻōlelo a ke kauka.

Hiki i nā pilikia o ka overdose kekahi mau hōʻailona e hoʻopilikia maikaʻi i kou kino:

  • hoʻonui hoʻonui ʻia.
  • ka hoʻomohala ʻana o ka hypoglycemia;
  • lie kanikela
  • ʻʻAla
  • ka hoʻomohala ʻana o ka hypoglycemia koʻikoʻi;
  • nunui o nā wāwae;
  • ʻO ka comog hypoglycemic maʻi (e pili ana i ka hoʻomohala ʻana i kahi maʻi hypoglycemia maʻalahi a hiki ke hoʻoholo i nā hōʻailona ma luna).
Ke hele a hoʻonāukiuki hypoglycemia, pono ke komo ʻana i ka huapalapala. I ka hanana e piʻi ana ka maʻi i ka hypoglycemia koʻikoʻi, pono ke hāʻawi ʻia i ka mea maʻi i kahi hoʻonā glucose infravenous glucose.

Kūʻai a me nā hoʻohālikelike

ʻO ka kumukūʻai kūpono no ka ʻeke (30 mau pcs.) O nā papa Novonorm 1 mg he 160-170 rubles, 2 mg - 210-220 rubles. ʻO kahi analogue o ka lāʻau lapaʻau ka Diclinid.

Nā wikiō pili

Hōʻikeʻike o nā lāʻau maʻi maʻi:

ʻO ka lāʻau hōʻaʻo Novonorm he hana wikiwiki wikiwiki i ka sela insulin. ʻO nā loiloi e pili ana i kēia lāʻau lapaʻau ka mea kūpono loa. Holo koke ia i ka pae o ka glucose i ke koko. ʻO kēia ke kumu o ka hoʻouluʻana o ka insulin e ka pancreas. A kūpaʻa ka hopena o ka lāʻau i ka nui o nā hana e pono ai nā b-nā mea i mālama ʻia i nā loko o nā kelepona. Kau ʻia ka lāʻau lapaʻau me ka papa ʻaina a me ka hana maʻamau ma ke ʻano he supplement.

Pin
Send
Share
Send